A158 COMPARING CORTIMENT® AND PREDNISONE IN ULCERTATIVE COLITIS: A POPULATION-BASED STUDY OF OUTCOMES

BACKGROUND: In August 2016 Cortiment® was approved for use in ulcerative colitis (UC) patients in Canada, but not approved for reimbursement; the Canadian Agency for Drugs and Technology in Health cited no comparable benefit for its use over other approved UC medications. Real-world data comparing C...

Descripción completa

Detalles Bibliográficos
Autores principales: Coward, S, Martins, K, Klarenbach, S, Kroeker, K, Ma, C, Panaccione, R, Richer, L, Seow, C, Targownik, L E, Kaplan, G G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Poster of Distinction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859399/
http://dx.doi.org/10.1093/jcag/gwab049.157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859399/
http://dx.doi.org/10.1093/jcag/gwab049.157

Ejemplares similares